Palivizumab

From IDWiki

Jump to:navigation, search

Monoclonal antibody to RSV
Targets the F subunit
Limited indications (refer to RSV for details)
Main side effect is anaphylaxis
Cost about $5000 per patient per season, which reduces hospitalizations

Retrieved from "https://idwiki.org/index.php?title=Palivizumab&oldid=2755"

Antivirals